Search

Howard B Sosin

from Fairfield, CT
Age ~74

Howard Sosin Phones & Addresses

  • 640 Sasco Hill Rd, Fairfield, CT 06430 (203) 254-8383 (203) 256-5800 (203) 256-9438
  • 702 Sasco Hill Rd, Fairfield, CT 06430 (203) 256-8372
  • Tucson, AZ
  • Palm Beach, FL
  • Clermont, FL
  • Westport, CT
  • Hobe Sound, FL
  • Alta, UT
  • Southport, CT
  • Jupiter, FL

Business Records

Name / Title
Company / Classification
Phones & Addresses
Howard Sosin
Partner
ALLERTEIN THERAPEUTICS, LLC
640 Sasco Hl Rd, Fairfield, CT 06824
Howard Sosin
Principal
Jaz Computer Products
Ret Computers/Software
Southport, CT 06890
702 Sasco Hl Rd, Fairfield, CT 06824
Howard B. Sosin
President
VHGO CORP
Joseph F Mckeon, Westport, CT 06880
1175 Post Rd E, Westport, CT 06880
640 Sasco Hl Rd, Southport, CT 06490

Publications

Wikipedia

Howard Sosin

View page

Howard Sosin was born in Illinois and became a financial whiz. He was for a time an associate Professor at the Columbia Business School. He founded American International Group ...

Us Patents

Block Putter

View page
US Patent:
6595867, Jul 22, 2003
Filed:
Aug 30, 2001
Appl. No.:
09/943364
Inventors:
Howard Sosin - Fairfield CT
Assignee:
Feil Golf, LLC - Fairfield CT
International Classification:
A63B 5300
US Classification:
473290, 473293, 473294, 473313, 473340, 473409
Abstract:
A block putter, usable with either a conventional or sidesaddle putting stance for a right-handed or left-handed golfer, having a head width in the range of about one half to about twice the width of a golf ball. The increased width and potentially increased weight of the putter head improve its performance both on the green and when hitting from the fringe, the fairway, or the rough, or out of the sand. The golfer may use the toe of the putter, rather than one of the faces, to strike the ball, for increased accuracy, especially on short putts. Alternatively, the golfer may putt in a sidesaddle stance with the traditional putter face using a putter having an elongated shaft. The elongated shaft is of such a length as to allow for the end of the shaft to rest on the golfers shoulder and help stabilize the putt.

Method And Apparatus For The Customization Of Boot Placement On Skis

View page
US Patent:
6715782, Apr 6, 2004
Filed:
Jan 31, 2001
Appl. No.:
09/774522
Inventors:
Clifford Sosin - Southport CT, 06490
Howard B. Sosin - Southport CT, 06490
International Classification:
A63C 500
US Classification:
280607, 280 1114, 280 1421
Abstract:
A method and apparatus is disclosed that allows a user to individually or simultaneously customize the pitch, roll, height, yaw, linear placement and lateral placement of his/her boots on his/her skis. This system allows the user to stand in a position while skiing that is closer to his/her natural position and to have the parameters of such a stance measured and quantified, thereby improving comfort, performance, and safety. As opposed to the limited variation in only some parameters described by current art, this invention allows significant variation in all individual parameters and simultaneous customization of all parameters. This simultaneity is important because of its increased ease to the skier and because altering any one parameter can change the center of pressure, thus creating the need for additional changes until the perfect combination of adjustments is made. In particular, the system allows for the alteration of the yaw of the ski boot alone or in combination with any or all of the other parameters.

Microbial Delivery System

View page
US Patent:
8153414, Apr 10, 2012
Filed:
Dec 6, 2000
Appl. No.:
09/731375
Inventors:
Michael J. Caplan - Woodbridge CT, US
Hugh A. Sampson - Larchmont NY, US
A. Wesley Burks - Chapel Hill NC, US
H. Kim Bottomly - Wellesley MA, US
Howard B. Sosin - Fairfield CT, US
Assignee:
Allertein Therapeutics, LLC - Fairfield CT
International Classification:
C12N 1/20
C12N 15/70
C07H 21/04
A61K 39/35
US Classification:
4352528, 4353201, 536 236, 4242751
Abstract:
The present invention provides methods and compositions for treating or preventing allergic responses, particularly anaphylactic allergic responses, in subjects who are allergic to allergens or susceptible to allergies. Methods of the present invention utilize administration of microorganisms to subjects, where the microorganisms produce allergens and protect the subjects from exposure to the allergens until phagocytosed by antigen-presenting cells. Particularly preferred microorganisms are gram-negative bacteria, gram-positive bacteria, and yeast. Particularly preferred allergens are proteins found in foods, venoms, drugs and latex that elicit allergic reactions and anaphylactic allergic reactions in individuals who are allergic to the proteins or are susceptible to allergies to the proteins. The proteins may also be modified to reduce the ability of the proteins to bind and crosslink IgE antibodies and thereby reduce the risk of eliciting anaphylaxis without affecting T-cell mediated Th1-type immunity.

Methods And Reagents For Decreasing Clinical Reaction To Allergy

View page
US Patent:
8246945, Aug 21, 2012
Filed:
Oct 2, 2009
Appl. No.:
12/572599
Inventors:
Michael J. Caplan - Woodbridge CT, US
H. Kim Bottomly - Wellesley MA, US
Howard B. Sosin - Fairfield CT, US
A. Wesley Burks - Chapel Hill NC, US
Hugh A. Sampson - Larchmont NY, US
Assignee:
University of Arkansas - Little Rock AR
Mount Sinai School of Medicine of New York University - New York NY
Allertein Therapeutics, LLC - Fairfield CT
International Classification:
C12N 1/21
C12N 15/70
A61K 39/35
A61K 39/36
A61K 39/40
US Classification:
424 932, 424 934, 4242411, 4242751, 43525233, 536 236
Abstract:
The present invention provides methods and compositions for treating or preventing allergic reactions, particularly anaphylactic reactions. Methods of the present invention involve administering microorganisms to allergic subjects, where the microorganisms contain a recombinant version of the protein allergen. The recombinant version can be wild-type or may include mutations within IgE epitopes of the protein allergen. Preferably the compositions are administered rectally. Particularly preferred microorganisms are bacteria such as. Any allergen may be used in the inventive methods. Particularly preferred allergens are anaphylactic allergens including protein allergens found in foods, venoms, drugs and latex. The inventive compositions and methods are demonstrated in the treatment of peanut-induced anaphylaxis.

Block Putter

View page
US Patent:
20020025855, Feb 28, 2002
Filed:
May 8, 2001
Appl. No.:
09/851050
Inventors:
Howard Sosin - Fairfield CT, US
International Classification:
A63B053/04
A63B069/36
US Classification:
473/297000
Abstract:
A block putter, usable with either a conventional or sidesaddle putting stance for a right-handed or left-handed golfer, having a head width in the range of about one half to about twice the width of a golf ball. The increased width and potentially increased weight of the putter head improve its performance both on the green and when hitting from the fringe, the fairway, or the rough, or out of the sand. The golfer may use the toe of the putter, rather than one of the faces, to strike the ball, for increased accuracy, especially on short putts.

Block Putter

View page
US Patent:
20020025858, Feb 28, 2002
Filed:
Jun 4, 2001
Appl. No.:
09/874658
Inventors:
Howard Sosin - Fairfield CT, US
International Classification:
A63B069/36
A63B053/04
US Classification:
473/340000, 473/294000, 473/293000
Abstract:
A block putter, usable with either a conventional or sidesaddle putting stance for a right-handed or left-handed golfer, having a head width in the range of about one half to about twice the width of a golf ball. The increased width and potentially increased weight of the putter head improve its performance both on the green and when hitting from the fringe, the fairway, or the rough, or out of the sand. The golfer may use the toe of the putter, rather than one of the faces, to strike the ball, for increased accuracy, especially on short putts. Alternatively, the golfer may putt in a sidesaddle stance with the traditional putter face using a putter having an elongated shaft. The elongated shaft is of such a length as to allow for the end of the shaft to rest on the golfer's shoulder and help stabilize the putt.

Methods To Block Ige Binding To Cell Surface Receptors Of Mast Cells

View page
US Patent:
20020076420, Jun 20, 2002
Filed:
Jun 15, 2001
Appl. No.:
09/882728
Inventors:
Michael Caplan - Woodbridge CT, US
Howard Sosin - Fairfield CT, US
International Classification:
A61K039/35
A61K039/36
US Classification:
424/275100
Abstract:
Compositions are administered to block IgE binding to receptors and ultimately displace native IgE from mast cells and related cell types, to prevent the activation of these cells during an allergic response. The compositions consist of a pharmaceutically acceptable carrier for systemic or local administration and an amount of compound binding specifically to the Fc RI IgE binding sites, and more preferably, Fc RI and Fc RII IgE binding sites, to prevent activation and degranulation of mast cells in response to exposure to allergens. The compounds can consist of IgE molecules and fragments and modifications thereof, such as IgE fragments, humanized or single chain IgE antibodies or fragments thereof, IgE with a modified Fab, non-crosslinkable IgE, or peptidomimetics which bind to the same site on the receptor as the IgE, jointly referred to herein as “IgE fragments” unless otherwise stated.

System For Controlling Immune System Response To Antigen

View page
US Patent:
20020090381, Jul 11, 2002
Filed:
Apr 9, 1999
Appl. No.:
09/290029
Inventors:
H. KIM BOTTOMLY - NEW HAVEN CT, US
MICHAEL J. CAPLAN - WOODBRIDGE CT, US
HOWARD B. SOSIN - FAIRFIELD CT, US
International Classification:
A61K039/395
C12N005/16
C07K017/00
C07K014/00
US Classification:
424/198100, 435/326000, 530/351000
Abstract:
The present invention provides compositions and methods for regulating immune system reactions by biasing T cell responses away from Th1 or Th2 responses in a pre-determined manner. Control is effected at the stage of antigen/APC encounter and/or at the stage of APC/T cell encounter. In preferred embodiments, a Th1 or Th2 response is inhibited through induction of the alternative response. The inventive methods and reagents are particularly useful for the management of autoimmune disorders, allergy, and asthma.
Howard B Sosin from Fairfield, CT, age ~74 Get Report